ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,13 € ↓ -0,20 (-3,16%)
2026-06-05
DEL PRIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionBell & Brown Wealth Advisors, Llc
Latest Disclosed Ownership75,050 shares
Latest Disclosed Value $ 575,634
Bell & Brown Wealth Advisors, Llc reports 9.20% decrease in ownership of 26CA / ImmunityBio, Inc.

On May 11, 2026 - Bell & Brown Wealth Advisors, Llc filed a 13F-HR form disclosing ownership of 75,050 shares of ImmunityBio, Inc. (DE:26CA) valued at $492,328 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 13, 2026 disclosing 82,650 shares of ImmunityBio, Inc.. This represents a change in shares of -9.20% during the quarter. The current value of the position is $460,056 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F IMMUNITYBIO COM 45256X103 75,050 -7,600 -9.20 576 252.76 0.1867
2026-05-13 2025-12-31 13F/A-1 IMMUNITYBIO COM 45256X103 82,650 -100 -0.12 164 -19.70 0.0527
2026-01-30 2025-12-31 13F IMMUNITYBIO COM 45256X103 82,650 -100 164 0.0527
2025-11-07 2025-09-30 13F IMMUNITYBIO COM 45256X103 82,750 5,000 6.43 204 -0.98 0.0667
2025-07-29 2025-06-30 13F IMMUNITYBIO COM 45256X103 77,750 19,050 32.45 205 16.48 0.0734
2025-05-07 2025-03-31 13F IMMUNITYBIO COM 45256X103 58,700 17,300 41.79 177 67.62 0.0689
2025-05-07 2024-12-31 13F IMMUNITYBIO COM 45256X103 41,400 4,500 12.20 106 -23.36 0.0394
2024-11-14 2024-09-30 13F IMMUNITYBIO COM 45256X103 36,900 2,500 7.27 137 -36.87 0.0537
2024-08-13 2024-06-30 13F IMMUNITYBIO COM 45256X103 34,400 100 0.29 217 17.93 0.0833
2024-05-13 2024-03-31 13F IMMUNITYBIO COM 45256X103 34,300 -100 -0.29 184 6.98 0.0788
2024-02-12 2023-12-31 13F IMMUNITYBIO COM 45256X103 34,400 14,300 71.14 173 212.73 0.0802
2023-08-15 2023-06-30 13F IMMUNITYBIO COM 45256X103 20,100 20,100 56 0.0280
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.